chr17-247138-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_006987.4(RPH3AL):c.586C>T(p.Arg196Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0000925 in 1,610,928 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00011 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000091 ( 0 hom. )
Consequence
RPH3AL
NM_006987.4 missense
NM_006987.4 missense
Scores
3
10
6
Clinical Significance
Conservation
PhyloP100: 4.92
Genes affected
RPH3AL (HGNC:10296): (rabphilin 3A like (without C2 domains)) The protein encoded by this gene plays a direct regulatory role in calcium-ion-dependent exocytosis in both endocrine and exocrine cells and plays a key role in insulin secretion by pancreatic cells. This gene is likely a tumor suppressor. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jun 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.26128182).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RPH3AL | NM_006987.4 | c.586C>T | p.Arg196Cys | missense_variant | 7/10 | ENST00000331302.12 | NP_008918.1 | |
RPH3AL | NM_001190411.2 | c.586C>T | p.Arg196Cys | missense_variant | 6/9 | NP_001177340.1 | ||
RPH3AL | NM_001190412.2 | c.499C>T | p.Arg167Cys | missense_variant | 6/9 | NP_001177341.1 | ||
RPH3AL | NM_001190413.2 | c.499C>T | p.Arg167Cys | missense_variant | 5/8 | NP_001177342.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RPH3AL | ENST00000331302.12 | c.586C>T | p.Arg196Cys | missense_variant | 7/10 | 2 | NM_006987.4 | ENSP00000328977 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000107 AC: 16AN: 149612Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
16
AN:
149612
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000119 AC: 30AN: 251202Hom.: 0 AF XY: 0.000118 AC XY: 16AN XY: 135786
GnomAD3 exomes
AF:
AC:
30
AN:
251202
Hom.:
AF XY:
AC XY:
16
AN XY:
135786
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000910 AC: 133AN: 1461316Hom.: 0 Cov.: 31 AF XY: 0.0000812 AC XY: 59AN XY: 726954
GnomAD4 exome
AF:
AC:
133
AN:
1461316
Hom.:
Cov.:
31
AF XY:
AC XY:
59
AN XY:
726954
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000107 AC: 16AN: 149612Hom.: 0 Cov.: 32 AF XY: 0.0000822 AC XY: 6AN XY: 73024
GnomAD4 genome
AF:
AC:
16
AN:
149612
Hom.:
Cov.:
32
AF XY:
AC XY:
6
AN XY:
73024
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
15
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 14, 2022 | The c.586C>T (p.R196C) alteration is located in exon 7 (coding exon 5) of the RPH3AL gene. This alteration results from a C to T substitution at nucleotide position 586, causing the arginine (R) at amino acid position 196 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Pathogenic
DEOGEN2
Benign
T;T;.;.;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Benign
D
LIST_S2
Uncertain
D;.;.;D;D
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T;T;T
MetaSVM
Uncertain
T
MutationAssessor
Uncertain
M;M;.;.;.
MutationTaster
Benign
D;D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
.;.;.;D;.
REVEL
Uncertain
Sift
Pathogenic
.;.;.;D;.
Sift4G
Pathogenic
D;D;D;D;.
Polyphen
D;D;D;D;.
Vest4
MutPred
Loss of MoRF binding (P = 0.0077);Loss of MoRF binding (P = 0.0077);.;.;Loss of MoRF binding (P = 0.0077);
MVP
MPC
0.39
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at